Update in thrombosis: answers to perplexing questions

Cleve Clin J Med. 2005 Oct;72(10):907-15. doi: 10.3949/ccjm.72.10.907.

Abstract

Recent clinical trials are answering some of the perplexing clinical questions about venous thromboembolism (VTE), such as the length and intensity of anticoagulation needed to prevent recurrence. We review some of these clinical trials and their implications for physicians and patients.

Publication types

  • Review

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Clinical Trials as Topic
  • Factor V
  • Humans
  • Risk Factors
  • Secondary Prevention
  • Thromboembolism / drug therapy*
  • Thromboembolism / genetics
  • Venous Thrombosis / drug therapy*
  • Venous Thrombosis / genetics
  • Warfarin / administration & dosage
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • factor V Leiden
  • Warfarin
  • Factor V